| Citation: | TAN Kai, WANG Guoyu, WU Yulin, YANG Xiaoping, XU Zuliang, LIU Hongyu. Influence of intrahepatic fat on the evaluation of hepatic fibrosis using different T1 mapping techniques[J]. Chinese Journal of General Practice, 2025, 23(7): 1196-1198. doi: 10.16766/j.cnki.issn.1674-4152.004096 |
| [1] |
丁成, 马语卓, 黄兴兆, 等. 牙周基础治疗对非酒精性脂肪性肝病伴牙周炎患者肝功能及血脂水平的影响[J]. 中华全科医学, 2021, 19(8): 1280-1282, 1299. doi: 10.16766/j.cnki.issn.1674-4152.002040
DING C, MA Y Z, HUANG X H, et al. Effect of periodontal basic treatment on liver function and lipid levels in periodontitis patients with non-alcoholic fatty liver disease[J]. Chinese Journal of General Practice, 2021, 19(8): 1280-1282, 1299. doi: 10.16766/j.cnki.issn.1674-4152.002040
|
| [2] |
王娟娟, 舍玲, 梁灿灿, 等. 非酒精性脂肪性肝病肝纤维化程度与心脏左心室改变的关系[J]. 医学研究杂志, 2024, 53(7): 79-84.
WANG J J, SHE L, LIANG C C, et al. Relationship between the degree of liver fibrosis and left ventricular changes in non-alcoholic fatty liver disease[J]. Journal of Medical Research, 2024, 53(7): 79-84.
|
| [3] |
TENG M L, NG C H, HUANG D Q, et al. Global incidence and prevalence of nonalcoholic fatty liver disease[J]. Clin Mol Hepatol, 2023, 29(Suppl): S32-S42. doi: 10.3350/cmh.2022.0365
|
| [4] |
EL-KASSAS M, CABEZAS J, COZ P I, et al. Nonalcoholic fatty liver disease: current global burden[J]. Semin Liver Dis, 2022, 42(3): 401-412. doi: 10.1055/a-1862-9088
|
| [5] |
SAIMAN Y, DUARTE-ROJO A, RINELLA M E. Fatty liver disease: diagnosis and stratification[J]. Annu Rev Med, 2022, 73(1): 529-544. doi: 10.1146/annurev-med-042220-020407
|
| [6] |
HAYASE J, BRADFIELD J. T1 Mapping: a complementary tool for substrate visualization[J]. JACC Clin Electrophysiol, 2023, 9(6): 749-750. doi: 10.1016/j.jacep.2023.01.038
|
| [7] |
VENKATESH S K, TORBENSON M S. Liver fibrosis quantification[J]. Abdom Radiol(NY), 2022, 47(3): 1032-1052. doi: 10.1007/s00261-021-03396-y
|
| [8] |
WEN X, FENG X, KANG Y, et al. Application progress of Gd-EOB-DTPA-enhanced MRI T1 mapping in hepatic diffuse diseases[J]. Curr Med Imaging, 2022, 18(12): 1276-1281. doi: 10.2174/1573405617666211130153450
|
| [9] |
JIANG Y L, ZOU J, FAN F X, et al. Application of multi-echo Dixon and MRS in quantifying hepatic fat content and staging liver fibrosis[J]. Sci Rep, 2023, 13(1): 12555. DOI: 10.1038/s41598-023-39361-6.
|
| [10] |
中华中医药学会脾胃病分会. 非酒精性脂肪性肝病中医诊疗专家共识(2023)[J]. 中国中西医结合消化杂志, 2024, 32(1): 1-7.
Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Expert consensus on Traditional Chinese Medicine diagnosis and treatment of non-alcoholic fatty liver disease(2023)[J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2024, 32(1): 1-7.
|
| [11] |
AMER J, ALNEES M, SALAMEH M, et al. The diagnostic utility of FIB-4 as a non-invasive tool for liver fibrosis scoring among NAFLD patients: a retrospective cross-sectional study[J]. Eur Rev Med Pharmacol Sci, 2024, 28(8): 3104-3111.
|
| [12] |
VON ULMENSTEIN S, BOGDANOVIC S, HONCHAROVA-BILETSKA H, et al. Assessment of hepatic fibrosis and inflammation with look-locker T1 mapping and magnetic resonance elastography with histopathology as reference standard[J]. Abdom Radiol(NY), 2022, 47(11): 3746-3757. doi: 10.1007/s00261-022-03647-6
|
| [13] |
DE LANGE C, THRANE K J, THOMASSEN K S, et al. Hepatic magnetic resonance T1-mapping and extracellular volume fraction compared to shear-wave elastography in pediatric Fontan-associated liver disease[J]. Pediatr Radiol, 2021, 51(1): 66-76. doi: 10.1007/s00247-020-04805-y
|
| [14] |
KLAUS J B, GOERKE U, KLARHÖFER M, et al. MRI Dixon fat-corrected look-locker T1 mapping for quantification of liver fibrosis and inflammation-a comparison with the non-fat-corrected shortened modified look-locker inversion recovery technique[J]. Invest Radiol, 2024, 59(11): 754-760. doi: 10.1097/RLI.0000000000001084
|
| [15] |
HIGASHI M, TANABE M, YAMANE M, et al. Impact of fat on the apparent T1 value of the liver: assessment by water-only derived T1 mapping[J]. Eur Radiol, 2023, 33(10): 6844-6851. doi: 10.1007/s00330-023-10052-0
|
| [16] |
THOMPSON R B, CHOW K, MAGER D, et al. Simultaneous proton density fat-fraction and R2* imaging with water-specific T1 mapping (PROFIT1): application in liver[J]. Magn Reson Med, 2021, 85(1): 223-238. doi: 10.1002/mrm.28434
|
| [17] |
WANG K, CUNHA G M, HASENSTAB K, et al. Deep learning for inference of hepatic proton density fat fraction from T1-weighted In-phase and opposed-phase MRI: retrospective analysis of population-based trial data[J]. AJR Am J Roentgenol, 2023, 221(5): 620-631. doi: 10.2214/AJR.23.29607
|
| [18] |
ELFAAL M, SUPERSAD A, FERGUSON C, et al. Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis[J]. World J Radiol, 2023, 15(10): 293-303. doi: 10.4329/wjr.v15.i10.293
|
| [19] |
LI J H, LU X, ZHU Z, et al. Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH[J]. Hepatology, 2023, 78(4): 1200-1208. doi: 10.1097/HEP.0000000000000417
|
| [20] |
TONET E, BAGGIANO A, PAVASINI R, et al. Current evidence on the diagnostic and prognostic role of native T1 mapping in heart diseases[J]. Trends Cardiovasc Med, 2021, 31(7): 448-454. doi: 10.1016/j.tcm.2020.08.001
|
| [21] |
ERDEN A, KURU ÖZ D, PEKER E, et al. MRI quantification techniques in fatty liver: the diagnostic performance of hepatic T1, T2, and stiffness measurements in relation to the proton density fat fraction[J]. Diagn Interv Radiol, 2021, 27(1): 7-14. doi: 10.5152/dir.2020.19654
|
| [22] |
FELLNER C, NICKEL M D, KANNENGIESSER S, et al. Water-fat separated T1 mapping in the liver and correlation to hepatic fat fraction[J]. Diagnostics(Basel), 2023, 13(2): 201. DOI: 10.3390/diagnostics13020201.
|